Thinking of joining a study?

Register your interest

NCT06456489 | RECRUITING | Active Rheumatoid Arthritis


Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Sponsor:

Sohag University

Information provided by (Responsible Party):

Ahmed Mahrous

Brief Summary:

Remission or low disease activity in active rheumatoid arthritis

Condition or disease

Active Rheumatoid Arthritis

Intervention/treatment

Solumedrol

Phase

PHASE3

Detailed Description:

Assessment of rheumatoid arthritis activity by Disease activity score DAS28, DAS28 Erythrocyte sedimentation rate (ESR), American college of rheumatology (ACR) 20, ACR 50, ACR 70 will be done at baseline and every month for 3 consecutive months for both groups.

Study Type : INTERVENTIONAL
Estimated Enrollment : 268 participants
Masking : SINGLE
Primary Purpose : TREATMENT
Official Title : Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis
Actual Study Start Date : 2024-05-01
Estimated Primary Completion Date : 2024-09-30
Estimated Study Completion Date : 2024-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 20 Years to 65 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Refractory rheumatoid arthritis patients
Exclusion Criteria
  • * Other connective tissue diseases
  • * Endocrine diseases such as DM and thyroid disorders

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Location Details

NCT06456489


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Egypt,

Al-Azhar Univrsity

Cairo, Egypt,

Loading...